Similarly, emerging research suggests that tRNA‐derived small RNAs, such as tsRNA‐GlyGCC, modulate oncogenic signaling pathways in CRC and contribute to chemoresistance by targeting SPIB within the JAK1/STAT6 pathway [20]. The gene discussed is STAT6; the disease is colorectal carcinoma.